Illinois delays vote on legalizing medical marijuana

SPRINGFIELD, Illinois Wed Nov 28, 2012 6:48pm EST

Cannabis plants that will soon be harvested grow at Northwest Patient Resource Center in Seattle, Washington January 27, 2012. REUTERS/Cliff DesPeaux

Cannabis plants that will soon be harvested grow at Northwest Patient Resource Center in Seattle, Washington January 27, 2012.

Credit: Reuters/Cliff DesPeaux

Related Topics

SPRINGFIELD, Illinois (Reuters) - The Illinois General Assembly on Wednesday put off a vote to legalize marijuana use for medical purposes because the measure lacked the support for approval, its chief sponsor said.

Democratic Representative Lou Lang did not request a vote on his proposal because he did not want it to fail.

"He didn't call it because he was short of the votes," said Lang's spokeswoman, Beth Hamilton. Lang had earlier predicted the measure would pass if a few undecided members shifted to support.

The proposal for a three-year pilot program would make Illinois the second most populous state in the nation after California to allow medical marijuana. Nineteen states and the District of Columbia have legalized medical marijuana. Colorado and Washington state voters decided on November 6 to allow recreational use of cannabis.

Lang said he could try again to pass the proposal when the Illinois legislature meets in early December.

The Illinois bill would be the most restrictive in the country, according to Lang.

Some Republicans in the Illinois House said they opposed legalizing medical marijuana because it could be a "gateway drug" to abuse of other illegal substances. Others said they were not convinced that the benefits of smoking marijuana for certain medical conditions outweighed the potential negative consequences.

Under the Illinois bill, patients would have to be diagnosed with one of 30 debilitating medical conditions, register with the Department of Public Health and have written certification from their physician. Patients would be limited to no more than 2.5 ounces (70 grams) of marijuana every two weeks.

Under U.S. federal law, marijuana is considered an addictive substance and distribution is a federal offense. Federal law prohibits physicians from writing prescriptions, so many have issued "referrals" or "recommendations." The administration of President Barack Obama has discouraged federal prosecutors from pursuing people who distribute marijuana for medical purposes under state laws.

(Editing by Greg McCune, Mohammad Zargham and Leslie Adler)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (4)
GustavoP. wrote:
“…Republican Illinois representative Tom Morrison said he would oppose the legislation, calling marijuana a “gateway drug” that leads to abuse of other illegal drugs…”

Tom my friend, you sir are an ignoramus. How could legal medical marijuana lead to the abuse of harder drugs exactly if it’s taken out of the black market where these harder drugs are found?? Prohibition of Marijuana is the gateway to other harder drugs. Take Marijuana out of the black market and the “gateway” effect goes away. To me Mr.Morrison is just a coward of progress.

Nov 28, 2012 11:49am EST  --  Report as abuse
if marijuana were medicine then what would the large pharmaceutical corporations do? we should wait until they can patent it then sell it for huge profits.

Nov 28, 2012 5:17pm EST  --  Report as abuse
totherepublic wrote:
If ILL really wanted to do something smart they would follow suit with Washington and Colorado and eliminate about half their crime and have revenue to “burn”. Pardon the pun. The mob went down in Chicago when prohibition was repealed. Everybody knows how the bros like their weed.

Nov 28, 2012 5:45pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.